Results 31 to 40 of about 2,577,172 (407)

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

open access: yesAmerican Journal of Psychiatry, 2018
OBJECTIVE: In addition to N-methyl-d-aspartate receptor antagonism, ketamine produces opioid system activation. The objective of this study was to determine whether opioid receptor antagonism prior to administration of intravenous ketamine attenuates its
N. Williams   +10 more
semanticscholar   +1 more source

The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review

open access: yesPharmacy, 2022
The opioid epidemic is an ongoing public health crisis, and the United States health system is overwhelmed with increasing numbers of opioid-related overdoses.
Colleen G. Jordan   +5 more
doaj   +1 more source

Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation [PDF]

open access: yes, 2017
Mu opioid receptor selective antagonists are highly desirable because of their utility as pharmacological probes for receptor characterization and functional studies.
Wang, Huiqun   +2 more
core   +2 more sources

Update on opioid receptors

open access: yesBritish Journal of Anaesthesia, 1994
82100
ATCHESON, R, LAMBERT, DG
openaire   +4 more sources

Chronic morphine treatment attenuates cell growth of human BT474 breast cancer cells by rearrangement of the ErbB signalling network. [PDF]

open access: yes, 2013
There is increasing evidence that opioid analgesics may interfere with tumour growth. It is currently thought that these effects are mediated by transactivation of receptor tyrosine kinase (RTK)-controlled ERK1/2 and Akt signalling.
Ammer, Hermann   +2 more
core   +2 more sources

Untangling the complexity of opioid receptor function

open access: yesNeuropsychopharmacology, 2018
Mu opioid receptor agonists are among the most powerful analgesic medications but also among the most addictive. The current opioid crisis has energized a quest to develop opioid analgesics that are devoid of untoward effects.
R. Valentino, N. Volkow
semanticscholar   +1 more source

Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice

open access: yesHaematologica, 2015
Treatment of pain with morphine and its congeners in sickle cell anemia is suboptimal, warranting the need for analgesics devoid of side effects, addiction and tolerance liability. Small-molecule nociceptin opioid receptor ligands show analgesic efficacy
Derek Vang   +7 more
doaj   +1 more source

Morphine activates neuroinflammation in a manner parallel to endotoxin [PDF]

open access: yes, 2012
Opioids create a neuroinflammatory response within the CNS, compromising opioid-induced analgesia and contributing to various unwanted actions. How this occurs is unknown but has been assumed to be via classic opioid receptors.
A. A. Somogyi   +42 more
core   +2 more sources

Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists

open access: yesScience Advances, 2019
Crystal structures provide first atomic-level insights into δ-opioid receptor activation by two structurally diverse agonists. Selective activation of the δ-opioid receptor (DOP) has great potential for the treatment of chronic pain, benefitting from ...
T. Claff   +18 more
semanticscholar   +1 more source

Specific down-regulation of spinal μ-opioid receptor and reduced analgesic effects of morphine in mice with postherpetic pain [PDF]

open access: yes, 2006
The analgesic effects of opioid agonists and the expression of μ-and κ-opioid receptors were compared between mice with herpetic pain and those with postherpetic pain induced by herpetic virus inoculation.
Kuraishi Yasushi   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy